Table 3.
Chinese medicine ingredient code correspondence table.
| MOLID | MOLName |
|---|---|
| MOL001919 | (3S,5R,8R,9R,10S,14S)-3,17-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9-hexahydro-1H-cyclopenta [a]phenanthrene-15,16-dione |
| MOL001924 | paeoniflorin |
| MOL000211 | Mairin |
| MOL000358 | beta-sitosterol |
| MOL000359 | sitosterol |
| MOL000422 | kaempferol |
| MOL000492 | (+)-catechin |
| MOL000022 | 14-acetyl-12-senecioyl-2E,8Z,10E-atractylentriol |
| MOL000033 | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R,5S)-5-propan-2-yloctan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta [a]phenanthren-3-ol |
| MOL000049 | 3β-acetoxyatractylone |
| MOL000072 | 8β-ethoxy atractylenolide III |
| MOL001006 | poriferasta-7, 22E-dien-3 beta-ol |
| MOL002140 | Perlolyrine |
| MOL003036 | ZINC03978781 |
| MOL000449 | Stigmasterol |
| MOL003896 | 7-Methoxy-2-methyl isoflavone |
| MOL005321 | Frutinone A |
| MOL000006 | luteolin |
| MOL006774 | stigmast-7-enol |
| MOL007059 | 3-beta-Hydroxymethyllenetanshiquinone |
| MOL007514 | methyl icosa-11,14-dienoate |
| MOL008397 | Daturilin |
| MOL008400 | glycitein |
| MOL008407 | (8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta [a]phenanthren-3-one |
| MOL008411 | 11-Hydroxyrankinidine |
| MOL006554 | Taraxerol |
| MOL008391 | 5alpha-Stigmastan-3,6-dione |
| MOL000273 | (2 R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta [a]phenanthren-17-yl]-6-methylhept-5-enoic acid |
| MOL000275 | trametenolic acid |
| MOL000296 | hederagenin |
| MOL000287 | 3 beta-Hydroxy-24-methylene-8-lanostene-21-oic acid |
| MOL000289 | pachymic acid |
| MOL002211 | 11,14-eicosadienoic acid |
| MOL002388 | Delphin_qt |
| MOL002392 | Deltoin |
| MOL002395 | Deoxyandrographolide |
| MOL002398 | Karanjin |
| MOL002397 | karakoline |
| MOL002401 | Neokadsuranic acid B |
| MOL002410 | 1-benzoylnapelline |
| MOL002419 | (R)-Norcoclaurine |